Compare IBRX & CBSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IBRX | CBSH |
|---|---|---|
| Founded | 2014 | 1865 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.2B | 8.0B |
| IPO Year | 2015 | 2008 |
| Metric | IBRX | CBSH |
|---|---|---|
| Price | $8.40 | $55.46 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 10 |
| Target Price | $14.25 | ★ $65.56 |
| AVG Volume (30 Days) | ★ 13.2M | 814.1K |
| Earning Date | 11-03-2026 | 10-20-2026 |
| Dividend Yield | N/A | ★ 1.98% |
| EPS Growth | ★ 38.71 | 4.39 |
| EPS | N/A | ★ 2.06 |
| Revenue | ★ $113,288,000.00 | N/A |
| Revenue This Year | $99.98 | $12.02 |
| Revenue Next Year | $108.29 | $3.89 |
| P/E Ratio | ★ N/A | $26.99 |
| Revenue Growth | ★ 668.31 | N/A |
| 52 Week Low | $1.95 | $46.99 |
| 52 Week High | $12.43 | $60.92 |
| Indicator | IBRX | CBSH |
|---|---|---|
| Relative Strength Index (RSI) | 42.89 | 47.37 |
| Support Level | $7.71 | $53.15 |
| Resistance Level | $8.51 | $55.95 |
| Average True Range (ATR) | 0.76 | 0.88 |
| MACD | -0.20 | 0.22 |
| Stochastic Oscillator | 9.68 | 63.51 |
ImmunityBio Inc is a biotechnology company focused on developing and commercializing next-generation immunotherapies designed to activate the patient's immune system and provide durable protection against cancer and infectious diseases. Its approach harnesses both the adaptive and innate immune systems with the Cancer BioShield platform. The platform is built around the proprietary IL-15 superagonist ANKTIVA (nogapendekin alfa inbakicept) and is supported by a portfolio that includes adenovirus-vectored vaccines, NK-cell therapies, and additional immunomodulators. The company operates in the United States and Europe, with the majority of its revenue coming from the United States.
Commerce Bancshares Inc operates as the bank holding company for Commerce Bank. The bank is engaged in the general banking business, providing a broad range of retail, mortgage banking, corporate, investment, trust, and asset management products and services to individuals, businesses, and municipalities. The company has three reportable segments. The Commercial segment provides lending, leasing, deposit, payment, and cash management services to business and government customers. The Retail Banking segment offers consumer deposits, consumer lending, mortgage banking, and debit and credit card services through its branch network. The Wealth segment provides trust, estate planning, brokerage, and investment management services to individual and institutional clients.